$414 Million is the total value of GREAT POINT PARTNERS LLC's 30 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 38.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $26,028,000 | +4.8% | 1,010,000 | +26.2% | 6.29% | +14.0% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $24,160,000 | +98.5% | 550,592 | +175.3% | 5.84% | +115.9% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $24,129,000 | – | 155,000 | +100.0% | 5.83% | – |
| CYTK | Buy | CYTOKINETICS INC | $23,927,000 | +50.0% | 650,000 | +85.7% | 5.78% | +63.2% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $23,291,000 | +266.1% | 1,423,682 | +265.0% | 5.63% | +298.4% |
| GLPG | Buy | GALAPAGOS NVspon adr | $22,327,000 | +35.0% | 360,000 | +20.0% | 5.40% | +46.9% |
| PCVX | Buy | VAXCYTE INC | $21,376,000 | +79.7% | 885,153 | +77.0% | 5.17% | +95.5% |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $21,322,000 | +31.9% | 790,000 | +10.1% | 5.15% | +43.5% |
| ANAB | Buy | ANAPTYSBIO INC | $17,318,000 | -15.9% | 700,000 | +18.2% | 4.18% | -8.5% |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $16,418,000 | +1438.7% | 2,060,000 | +981.3% | 3.97% | +1574.3% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $16,248,000 | +39.7% | 942,445 | +17.8% | 3.93% | +52.0% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $12,886,000 | +136.4% | 874,197 | +112.2% | 3.11% | +157.1% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $11,114,000 | +75.9% | 1,118,067 | +108.3% | 2.69% | +91.4% |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $6,663,000 | +13.7% | 2,199,076 | +41.9% | 1.61% | +23.7% |
| ARDX | New | ARDELYX INC | $5,095,000 | – | 4,761,905 | +100.0% | 1.23% | – |
| New | VENTYX BIOSCIENCES INC | $4,564,000 | – | 336,334 | +100.0% | 1.10% | – | |
| ABOS | New | ACUMEN PHARMACEUTICALS INC | $3,630,000 | – | 928,282 | +100.0% | 0.88% | – |
| New | CINCOR PHARMA INC | $1,397,000 | – | 79,670 | +100.0% | 0.34% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-06-05 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.